Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Jun 08, 2021 2:31pm
535 Views
Post# 33348875

Online AGM June 30

Online AGM June 30
THERALASE
 
TECHNOLOGIES INC. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
 
TO THE SHAREHOLDERS:
 
NOTICE IS HEREBY GIVEN that the Annual General and Special Meeting (the “Meeting”) of the Shareholders of Theralase Technologies Inc. ("Corporation") will held on Wednesday, June 30, 2021, virtually via live audio webcast available online using the TSX meeting platform at https://virtual-meetings.tsxtrust.com/1181 at 5:30 p.m. (Toronto time), for the purposes of:
 
a) electing directors of the Corporation for the ensuing year;

b) appointing the auditors of the Corporation for the ensuing year and authorizing the directors, acting through the Audit Committee, to fix the remuneration to be paid to the auditors;

c) receiving and considering the audited consolidated financial statements for the fiscal year ended December 31, 2020 and the report of the auditors thereon;

d) re-approving the Corporation’s Incentive Stock Option Plan, as described in the Management Information Circular;

e) transacting such other business as may properly come before the Meeting.
 
Registered shareholders of record as of the close of business on May 31, 2021, the record date for the Meeting and duly appointed proxyholders can attend the online only Meeting at:
 
Webcast: https://virtual-meetings.tsxtrust.com/1181
<< Previous
Bullboard Posts
Next >>